Tag: Johnson & Johnson

India’s fight against COVID-19 receives boost from J&J’s single-shot vaccine

Frank

INDIA- India expects to receive its first doses of Johnson & Johnson COVID-19 vaccine filled and finished in the country by American drugmaker’s partner Biological E. Last month, India’s drug regulator granted emergency approval to the J&J vaccine, whether imported or locally filled and finished by J&J’s Indian partner, Biological E. The Asian nation could receive up to 43.5 million doses of the single-shot vaccine in October, which would be a significant step toward helping India meet its target of producing more than 300 million doses in the month. Based…

Read More

J&J Ebola vaccine shows promising results in latest study

Frank

USA – Johnson & Johnson has announced that its Ebola vaccine regimen has demonstrated remarkable antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. According to the report, the two-dose regimen was well-tolerated and induced antibody responses to the Zaire ebolavirus species, 21 days after the second dose in 98 per cent of all participants. The regimen, Zabdeno and Mvabea, generated immune responses that persisted in adults for at least two years. “These peer-reviewed data support the prophylactic use of the Johnson &…

Read More

J&J vaccine shipments from South Africa to Europe halted

Frank

SOUTH AFRICA – Strive Masiyiwa, an envoy of the African Union (AU) has made known to the public that the J&J vaccines manufacture by South Africa’s leading drug manufacturer, Aspen, will no longer be exported to Europe. The shots packaged by J&J’s South African partner Aspen that were already sent to Europe would be returned, Masiyiwa told a news briefing organized by the AU’s disease control body. J&J had shipped less than 20 million doses to Europe, he said, and the halting of the shipments was partly due to interventions…

Read More

Johnson & Johnson’s HIV vaccine fails mid-stage study in Africa

Frank

AFRICA – Johnson & Johnson (JNJ.N) has said its experimental vaccine failed to provide enough protection against HIV in sub-Saharan Africa to young women who are at high risk of being infected. The mid-stage trial failure highlights the challenges of vaccine development, especially for HIV or human immunodeficiency virus, which has no approved vaccines. “HIV is a unique and complex virus that has long posed unprecedented challenges for vaccine development because of its ability to attack, hijack and evade the human immune system,” Paul Stoffels, J&J’s chief scientific officer, said…

Read More

Johnson & Johnson seeks to conduct COVID-19 vaccine trial in Indian adolescents

Frank

INDIA – US pharma giant Johnson & Johnson has submitted an application to India’s Central Drugs Standard Control Organization (CDSCO) seeking permission to conduct clinical trials of its single shot Janssen vaccine against Covid-19 on adolescents aged 12-17 years. Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the Coronavirus, J&J said in an emailed statement. J&J’s one-shot vaccine has been found to have efficacy of 85.4% against severe disease and 93.1% against hospitalization. The U.S. pharma giant had received emergency use approval for its single-dose…

Read More

Afrexim bank to distribute Johnson and Johnson vaccine to Nigerians at US$7.50

Frank

NIGERIA – The African Export-Import Bank (Afreximbank), which facilitated the procurement of the Johnson & Johnson (J&J), Janssen Pharmaceuticals’ vaccine has said each dose will be offered at US$7.50 as against US$10. The bank’s Regional Chief Operating officer, Mr Abdoulaye Kone, who disclosed this in an interview, said that the country would be procuring about 29,850,000 doses, through the African Union’s African Vaccine Acquisition Trust (AVAT). Following the receipt of the shipment of 177,600 doses on Thursday, Nigeria becomes one of the earliest beneficiaries of the supply deal agreed in…

Read More

African Vaccine Acquisition Trust delivers 108,000 doses of COVID-19 vaccine to Botswana

Frank

BOTSWANA – AVAT has shipped 108,000 doses of the Johnson & Johnson single-shot vaccines to Botswana as part of a total of 6.4 million vaccine doses to be shipped to African Union Member States this month. The Member States who have ordered vaccines through AVAT will continue to receive shipments for the next following months. In collaboration with the Africa Medical Supplies Platform (AMSP), UNICEF is providing logistical and delivery services to the Member States. These deliveries are part of the historic COVID-19 vaccine advance procurement agreement signed on 28…

Read More

Nigeria receives 177,600 doses of Johnson & Johnson vaccines

Frank

NIGERIA – Nigeria has received 177,600 Janssen (Johnson & Johnson) vaccines, marking the first wave of arrivals of COVID-19 vaccines procured through the African Union. “The arrival of these vaccines will be yet another step in the battle against the COVID-19 pandemic,” says Dr Faisal Shuaib, Executive Director of the National Primary Health Care Development Agency (NPHCDA). He adds that the shipment, is the first batch of the vaccine from the African Union which would be received in segments monthly until total 29.8 million doses are completed. Speaking on the…

Read More

Johnson and Johnson COVID-19 vaccine granted emergency use approval in India

Frank

INDIA – Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya announced. He said this will further boost the country’s collective fight against the novel coronavirus infection. “India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has five EUA vaccines. This will further boost our nation’s collective fight against,” the minister tweeted. The US-based pharmaceutical company had applied for Emergency Use Authorization for its jab on Friday and…

Read More

J&J seeks emergency use nod for COVID-19 vaccine in India

Frank

INDIA – Global healthcare major Johnson & Johnson has applied for emergency use approval of its coronavirus vaccine in India, moving a step closer to supplying the first single-dose COVID-19 shot to the country. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, J&J said in an emailed statement. “Biological E will…

Read More